Cofttek is a manufacturer of Nicotinamide Mononucleotide (nmn) powder buik. The monthly production capacity is 2300kg. Anti-aging research has shown that supplementation with NMN, a key NAD+ intermediate, is effective at mitigating age-associated metabolic decline and slowing the progression of a multitude of age-related diseases. Nicotinamide Mononucleotide powder has beneficial effects on the production of energy at the cellular level, improves tolerance to glucose, reduces inflammation, helps preserve the circulatory system, repairs DNA, and has beneficial effects on the preservation of cognitive function. NMN has also shown potential as a therapeutic agent against neurodegenerative disorders typical of old age.